SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) February 22, 2017

Cigna Corporation
(Exact name of registrant as specified in its charter)


Delaware
(State or other jurisdiction of incorporation)
108323
(Commission File Number)
061059331
(IRS Employer
Identification No.)
 
900 Cottage Grove Road
Bloomfield, Connecticut 06002
(Address of principal executive offices)  (Zip Code)


Registrant's telephone number, including area code:
(860) 226-6000


Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02              Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 22, 2017, Thomas A. McCarthy, Executive Vice President and Chief Financial Officer of Cigna Corporation (the "Company"), notified the Company of his intention to retire from his position in the early summer of 2017.  The terms of any retirement arrangement between the Company and Mr. McCarthy will be disclosed on a Form 8-K as required.

On February 23, 2017, the Company appointed Matthew G. Manders, who was most recently the Company's President of U.S. Markets, to the new role of President, Government & Individual Programs and Group Insurance.

Item 7.01             Regulation FD Disclosure.

A copy of the press release announcing Mr. McCarthy's retirement, Mr. Manders' appointment and other enterprise leadership team changes is furnished with this report as Exhibit 99.1 and is incorporated herein by reference.

The information in this Item 7.01 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act whether made before or after the date of this report, except as shall be expressly set forth by specific reference in such a filing.

 
Item 9.01            Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.
Description
   
99.1








SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
Cigna Corporation
     
     
     
Date:  February 23, 2017
By:
/s/ Nicole S. Jones
   
Nicole S. Jones
   
Executive Vice President
   
and General Counsel




 

Exhibit Index

Exhibit No.
Description
   
99.1